Literature DB >> 29873711

Conserved residues Arg188 and Asp302 are critical for active site organization and catalysis in human ABO(H) blood group A and B glycosyltransferases.

Susannah M L Gagnon1, Max S G Legg1, Robert Polakowski2, James A Letts1, Mattias Persson3, Shuangjun Lin2, Ruixiang Blake Zheng2, Brian Rempel2, Brock Schuman1, Omid Haji-Ghassemi1, Svetlana N Borisova1, Monica M Palcic1,2,3, Stephen V Evans1.   

Abstract

Homologous glycosyltransferases GTA and GTB perform the final step in human ABO(H) blood group A and B antigen synthesis by transferring the sugar moiety from donor UDP-GalNAc/UDP-Gal to the terminal H antigen disaccharide acceptor. Like other GT-A fold family 6 glycosyltransferases, GTA and GTB undergo major conformational changes in two mobile regions, the C-terminal tail and internal loop, to achieve the closed, catalytic state. These changes are known to establish a salt bridge network among conserved active site residues Arg188, Asp211 and Asp302, which move to accommodate a series of discrete donor conformations while promoting loop ordering and formation of the closed enzyme state. However, the individual significance of these residues in linking these processes remains unclear. Here, we report the kinetics and high-resolution structures of GTA/GTB mutants of residues 188 and 302. The structural data support a conserved salt bridge network critical to mobile polypeptide loop organization and stabilization of the catalytically competent donor conformation. Consistent with the X-ray crystal structures, the kinetic data suggest that disruption of this salt bridge network has a destabilizing effect on the transition state, emphasizing the importance of Arg188 and Asp302 in the glycosyltransfer reaction mechanism. The salt bridge network observed in GTA/GTB structures during substrate binding appears to be conserved not only among other Carbohydrate Active EnZyme family 6 glycosyltransferases but also within both retaining and inverting GT-A fold glycosyltransferases. Our findings augment recently published crystal structures, which have identified a correlation between donor substrate conformational changes and mobile loop ordering.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29873711      PMCID: PMC6054251          DOI: 10.1093/glycob/cwy051

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  54 in total

1.  Structure of Kre2p/Mnt1p: a yeast alpha1,2-mannosyltransferase involved in mannoprotein biosynthesis.

Authors:  Yuri D Lobsanov; Pedro A Romero; Barry Sleno; Bomina Yu; Patrick Yip; Annette Herscovics; P Lynne Howell
Journal:  J Biol Chem       Date:  2004-01-28       Impact factor: 5.157

2.  Donor substrate specificity of recombinant human blood group A, B and hybrid A/B glycosyltransferases expressed in Escherichia coli.

Authors:  N O Seto; C A Compston; S V Evans; D R Bundle; S A Narang; M M Palcic
Journal:  Eur J Biochem       Date:  1999-02

3.  Structural Snapshots of α-1,3-Galactosyltransferase with Native Substrates: Insight into the Catalytic Mechanism of Retaining Glycosyltransferases.

Authors:  David Albesa-Jové; M Ángela Sainz-Polo; Alberto Marina; Marcelo E Guerin
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-20       Impact factor: 15.336

4.  Computational design and experimental evaluation of glycosyltransferase mutants: engineering of a blood type B galactosyltransferase with enhanced glucosyltransferase activity.

Authors:  Taku Nakahara; Ole Hindsgaul; Monica M Palcic; Shin-Ichiro Nishimura
Journal:  Protein Eng Des Sel       Date:  2006-12       Impact factor: 1.650

5.  Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs.

Authors:  K Persson; H D Ly; M Dieckelmann; W W Wakarchuk; S G Withers; N C Strynadka
Journal:  Nat Struct Biol       Date:  2001-02

6.  Conformational analysis of a Chlamydia-specific disaccharide alpha-Kdo-(2-->8)-alpha-Kdo-(2-->O)-allyl in aqueous solution and bound to a monoclonal antibody: observation of intermolecular transfer NOEs.

Authors:  T Sokolowski; T Haselhorst; K Scheffler; R Weisemann; P Kosma; H Brade; L Brade; T Peters
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

7.  Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): role of negative charge on aspartic acid 316 in structure and activity.

Authors:  Percy Tumbale; Haryati Jamaluddin; Nethaji Thiyagarajan; Keith Brew; K Ravi Acharya
Journal:  Biochemistry       Date:  2008-07-24       Impact factor: 3.162

8.  Roles of individual enzyme-substrate interactions by alpha-1,3-galactosyltransferase in catalysis and specificity.

Authors:  Yingnan Zhang; G Jawahar Swaminathan; Ashlesha Deshpande; Ester Boix; Ramanathan Natesh; Zhihong Xie; K Ravi Acharya; Keith Brew
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

9.  Structure and Mechanism of Staphylococcus aureus TarS, the Wall Teichoic Acid β-glycosyltransferase Involved in Methicillin Resistance.

Authors:  Solmaz Sobhanifar; Liam J Worrall; Dustin T King; Gregory A Wasney; Lars Baumann; Robert T Gale; Michael Nosella; Eric D Brown; Stephen G Withers; Natalie C J Strynadka
Journal:  PLoS Pathog       Date:  2016-12-14       Impact factor: 6.823

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  2 in total

1.  Two novel mutations p. L319V and p. L91P in ABO glycosyltransferases lead to Ael and Bel phenotypes.

Authors:  Hang Lei; Zhongying Wang; Yuqing Wang; Dong Xiang; Xuefeng Wang; Xiaohong Cai
Journal:  Blood Transfus       Date:  2020-04-03       Impact factor: 3.443

2.  Deep evolutionary analysis reveals the design principles of fold A glycosyltransferases.

Authors:  Rahil Taujale; Aarya Venkat; Liang-Chin Huang; Zhongliang Zhou; Wayland Yeung; Khaled M Rasheed; Sheng Li; Arthur S Edison; Kelley W Moremen; Natarajan Kannan
Journal:  Elife       Date:  2020-04-01       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.